 | • レポートコード：MRC2-11QY11630 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病性足潰瘍治療薬のグローバル市場について調査・分析したレポートです。種類別（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子）市場規模、用途別（病院、専門クリニック、介護センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病性足潰瘍治療薬の競争状況、市場シェア ・世界の糖尿病性足潰瘍治療薬市場：種類別市場規模 2015年-2020年（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子） ・世界の糖尿病性足潰瘍治療薬市場：種類別市場規模予測 2021年-2026年（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子） ・世界の糖尿病性足潰瘍治療薬市場：用途別市場規模 2015年-2020年（病院、専門クリニック、介護センター、外来手術センター） ・世界の糖尿病性足潰瘍治療薬市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、介護センター、外来手術センター） ・北米の糖尿病性足潰瘍治療薬市場分析：米国、カナダ ・ヨーロッパの糖尿病性足潰瘍治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病性足潰瘍治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病性足潰瘍治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病性足潰瘍治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：B.Braun Melsungen、Smith & Nephew、Organogenesis、Derma Sciences、Sigvaris、3M、Acelity、Innocoll Holdings、SIGVARIS、Osiris ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing breakthrough advanced wound dressings for diabetic foot ulcer management. This includes novel dressings with the ability to confer moisture balance with prolonged time of action, extended oxygen permeability, antimicrobial activity, growth factor stimulation, and the ability to promote autolytic debridement thus facilitating the re-epithelialization process. This factor is creating robust development in the global diabetic foot ulcer therapeutics market.
A growing population affected by diabetes and a subsequent increase in the number of people afflicted with diabetic foot ulcer is likely to impact the global diabetic foot ulcer therapeutics market in a positive manner over the forecast period. Furthermore, continued prioritization to avoid surgeries and amputations is expected to fuel the growth of the global diabetic foot ulcer therapeutics market over the predicted period. Diabetes mellitus is one of the most important public health concerns worldwide, with an increased risk of developing diabetic foot ulcer. Hence, a number of clinical trials are being conducted currently wherein a large number of organizations are actively participating in extended research programs to develop novel therapies for diabetic foot ulcer treatment. Individuals with an increased risk of diabetes are demonstrating alarming hospitalization rates as a result of diabetes foot ulcer infection. This has resulted in a rise in the number of amputations. The occurrence of diabetes and associated risk factors are increasing at an alarming rate, which is expected to fuel revenue growth of the global diabetic foot ulcer therapeutics market during the period of assessment.
Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutics Market
The global Diabetic Foot Ulcer Therapeutics market size is projected to reach US$ 4355.6 million by 2026, from US$ 4057.6 million in 2020, at a CAGR of 6.8%% during 2021-2026.
Global Diabetic Foot Ulcer Therapeutics Scope and Market Size
Diabetic Foot Ulcer Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Foot Ulcer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
B.Braun Melsungen
Smith & Nephew
Organogenesis
Derma Sciences
Sigvaris
3M
Acelity
Innocoll Holdings
SIGVARIS
Osiris
Market segment by Type, the product can be split into
Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices
Growth Factors
Market segment by Application, split into
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetic Foot Ulcer Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Diabetic Foot Ulcer Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Advance Wound Dressings
1.4.3 Skin Substitutes
1.4.4 Negative Pressure Wound Therapy Devices
1.4.5 Growth Factors
1.5 Market by Application
1.5.1 Global Diabetic Foot Ulcer Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Long-Term Care Centers
1.5.5 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Foot Ulcer Therapeutics Market Perspective (2015-2026)
2.2 Global Diabetic Foot Ulcer Therapeutics Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetic Foot Ulcer Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetic Foot Ulcer Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetic Foot Ulcer Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Market Size
3.1.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetic Foot Ulcer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio
3.2.1 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetic Foot Ulcer Therapeutics Revenue in 2019
3.3 Diabetic Foot Ulcer Therapeutics Key Players Head office and Area Served
3.4 Key Players Diabetic Foot Ulcer Therapeutics Product Solution and Service
3.5 Date of Enter into Diabetic Foot Ulcer Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetic Foot Ulcer Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
5.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
6.2 Diabetic Foot Ulcer Therapeutics Key Players in North America (2019-2020)
6.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
6.4 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
7.2 Diabetic Foot Ulcer Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
7.4 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
8.2 Diabetic Foot Ulcer Therapeutics Key Players in China (2019-2020)
8.3 China Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
8.4 China Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
9.2 Diabetic Foot Ulcer Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
9.4 Japan Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
10.2 Diabetic Foot Ulcer Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
11.2 Diabetic Foot Ulcer Therapeutics Key Players in India (2019-2020)
11.3 India Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
11.4 India Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetic Foot Ulcer Therapeutics Market Size (2015-2020)
12.2 Diabetic Foot Ulcer Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 B.Braun Melsungen
13.1.1 B.Braun Melsungen Company Details
13.1.2 B.Braun Melsungen Business Overview
13.1.3 B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Introduction
13.1.4 B.Braun Melsungen Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020))
13.1.5 B.Braun Melsungen Recent Development
13.2 Smith & Nephew
13.2.1 Smith & Nephew Company Details
13.2.2 Smith & Nephew Business Overview
13.2.3 Smith & Nephew Diabetic Foot Ulcer Therapeutics Introduction
13.2.4 Smith & Nephew Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.2.5 Smith & Nephew Recent Development
13.3 Organogenesis
13.3.1 Organogenesis Company Details
13.3.2 Organogenesis Business Overview
13.3.3 Organogenesis Diabetic Foot Ulcer Therapeutics Introduction
13.3.4 Organogenesis Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.3.5 Organogenesis Recent Development
13.4 Derma Sciences
13.4.1 Derma Sciences Company Details
13.4.2 Derma Sciences Business Overview
13.4.3 Derma Sciences Diabetic Foot Ulcer Therapeutics Introduction
13.4.4 Derma Sciences Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.4.5 Derma Sciences Recent Development
13.5 Sigvaris
13.5.1 Sigvaris Company Details
13.5.2 Sigvaris Business Overview
13.5.3 Sigvaris Diabetic Foot Ulcer Therapeutics Introduction
13.5.4 Sigvaris Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.5.5 Sigvaris Recent Development
13.6 3M
13.6.1 3M Company Details
13.6.2 3M Business Overview
13.6.3 3M Diabetic Foot Ulcer Therapeutics Introduction
13.6.4 3M Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.6.5 3M Recent Development
13.7 Acelity
13.7.1 Acelity Company Details
13.7.2 Acelity Business Overview
13.7.3 Acelity Diabetic Foot Ulcer Therapeutics Introduction
13.7.4 Acelity Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.7.5 Acelity Recent Development
13.8 Innocoll Holdings
13.8.1 Innocoll Holdings Company Details
13.8.2 Innocoll Holdings Business Overview
13.8.3 Innocoll Holdings Diabetic Foot Ulcer Therapeutics Introduction
13.8.4 Innocoll Holdings Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.8.5 Innocoll Holdings Recent Development
13.9 SIGVARIS
13.9.1 SIGVARIS Company Details
13.9.2 SIGVARIS Business Overview
13.9.3 SIGVARIS Diabetic Foot Ulcer Therapeutics Introduction
13.9.4 SIGVARIS Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.9.5 SIGVARIS Recent Development
13.10 Osiris
13.10.1 Osiris Company Details
13.10.2 Osiris Business Overview
13.10.3 Osiris Diabetic Foot Ulcer Therapeutics Introduction
13.10.4 Osiris Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020)
13.10.5 Osiris Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetic Foot Ulcer Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetic Foot Ulcer Therapeutics Revenue
Table 3. Ranking of Global Top Diabetic Foot Ulcer Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetic Foot Ulcer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Advance Wound Dressings
Table 6. Key Players of Skin Substitutes
Table 7. Key Players of Negative Pressure Wound Therapy Devices
Table 8. Key Players of Growth Factors
Table 9. Global Diabetic Foot Ulcer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Diabetic Foot Ulcer Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Diabetic Foot Ulcer Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Diabetic Foot Ulcer Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Diabetic Foot Ulcer Therapeutics Players
Table 20. Global Diabetic Foot Ulcer Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Diabetic Foot Ulcer Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Diabetic Foot Ulcer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutics as of 2019)
Table 23. Global Diabetic Foot Ulcer Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Diabetic Foot Ulcer Therapeutics Product Solution and Service
Table 26. Date of Enter into Diabetic Foot Ulcer Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Diabetic Foot Ulcer Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Diabetic Foot Ulcer Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Diabetic Foot Ulcer Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 36. North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 38. North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 42. Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 48. China Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 50. China Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 54. Japan Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 66. India Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 68. India Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Diabetic Foot Ulcer Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Diabetic Foot Ulcer Therapeutics Market Share (2019-2020)
Table 72. Central & South America Diabetic Foot Ulcer Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Diabetic Foot Ulcer Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Diabetic Foot Ulcer Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Diabetic Foot Ulcer Therapeutics Market Share by Application (2015-2020)
Table 76. B.Braun Melsungen Company Details
Table 77. B.Braun Melsungen Business Overview
Table 78. B.Braun Melsungen Product
Table 79. B.Braun Melsungen Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 80. B.Braun Melsungen Recent Development
Table 81. Smith & Nephew Company Details
Table 82. Smith & Nephew Business Overview
Table 83. Smith & Nephew Product
Table 84. Smith & Nephew Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 85. Smith & Nephew Recent Development
Table 86. Organogenesis Company Details
Table 87. Organogenesis Business Overview
Table 88. Organogenesis Product
Table 89. Organogenesis Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 90. Organogenesis Recent Development
Table 91. Derma Sciences Company Details
Table 92. Derma Sciences Business Overview
Table 93. Derma Sciences Product
Table 94. Derma Sciences Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 95. Derma Sciences Recent Development
Table 96. Sigvaris Company Details
Table 97. Sigvaris Business Overview
Table 98. Sigvaris Product
Table 99. Sigvaris Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 100. Sigvaris Recent Development
Table 101. 3M Company Details
Table 102. 3M Business Overview
Table 103. 3M Product
Table 104. 3M Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 105. 3M Recent Development
Table 106. Acelity Company Details
Table 107. Acelity Business Overview
Table 108. Acelity Product
Table 109. Acelity Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 110. Acelity Recent Development
Table 111. Innocoll Holdings Business Overview
Table 112. Innocoll Holdings Product
Table 113. Innocoll Holdings Company Details
Table 114. Innocoll Holdings Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 115. Innocoll Holdings Recent Development
Table 116. SIGVARIS Company Details
Table 117. SIGVARIS Business Overview
Table 118. SIGVARIS Product
Table 119. SIGVARIS Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 120. SIGVARIS Recent Development
Table 121. Osiris Company Details
Table 122. Osiris Business Overview
Table 123. Osiris Product
Table 124. Osiris Revenue in Diabetic Foot Ulcer Therapeutics Business (2015-2020) (Million US$)
Table 125. Osiris Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Foot Ulcer Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Advance Wound Dressings Features
Figure 3. Skin Substitutes Features
Figure 4. Negative Pressure Wound Therapy Devices Features
Figure 5. Growth Factors Features
Figure 6. Global Diabetic Foot Ulcer Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Long-Term Care Centers Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Diabetic Foot Ulcer Therapeutics Report Years Considered
Figure 12. Global Diabetic Foot Ulcer Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Diabetic Foot Ulcer Therapeutics Market Share by Players in 2019
Figure 17. Global Top Diabetic Foot Ulcer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutics Revenue in 2019
Figure 19. North America Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
糖尿病性足潰瘍治療の世界市場（～2026年） Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutic Market The global Diabetic Foot Ulcer Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetic Foot Ulcer Therapeutic Scope and Market Si…- 糖尿病性足潰瘍・褥瘡の世界市場（～2026年） Diabetic foot ulcers, are most common chronic wounds in patients suffering from diabetes, and lack of proper treatment of the foot ulcers often lead to progression of the wound resulting in lower extremity / foot amputation. Pressure ulcers are often a cause of lack of movement of the patients, long…
- 高度創傷ケアの世界市場（～2026年） Advanced Wound Care products for the wound healing process are generally prescribed by clinicians after a visit to the doctor or hospital. Advanced Wound Care products generally includes film and foam dressings, hydrogels, alginates and hydrocolloids. Such products are largely focused on keeping the…
- 使い捨て陰圧閉鎖療法装置の世界市場（～2026年） Market Analysis and Insights: Global Disposable Negative Pressure Wound Therapy Devices Market The global Disposable Negative Pressure Wound Therapy Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Disposable Ne…
- 増殖性糖尿病性網膜症治療治療薬の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proliferative Diabe…